However, whether this represents early lung adenocarcinoma development is unclear, and recent studies have suggested that carcinogen-induced Kras mutations may differ between humans (typically G12C or G12D) and mouse models (Q61L and Q61R) [8,9]. Here, KRAS is linked to lung adenocarcinoma.